Mark J. Holterman, Medical

Three Patient Benefits of Cellular Therapies

 

Mark J Holterman
Mark J Holterman

A pediatric surgeon with more than two decades of experience, Mark Holterman, MD, teaches medical students and residents at the University of Illinois College of Medicine and serves as the chief medical officer for Mariam Global Health. Dr. Mark Holterman also maintains an interest in stem cell therapy and has published numerous articles on the subject. Stem cell therapies offer multiple benefits to patients, as outlined below.

1. Treats a wide range of conditions. From cardiovascular and neurodegenerative diseases to orthopedic injuries, cellular therapies can treat a broad spectrum of medical conditions. Research indicates that cellular therapies can help stimulate the repair and growth of blood vessel tissues surrounding the heart and offer relief from degenerative symptoms associated with neurodegenerative diseases. Medical researchers also suspect that adult stem cells may possess the ability to help patients with autoimmune diseases and diabetes.

2. Promotes wound healing. Stem cell therapy accelerates tissue growth and boosts the body’s production of collagen, a protein found in skin, muscles, bones, blood vessels, and the digestive system that strengthens skin and replaces dead cells. The increase of collagen concentration tightens damaged tissue and reduces scars by growing healthy tissue.

3. Improved success for transplants. Cellular therapies give patients the option to transplant cells from one area of their body to another, which decreases the possibility of a rejection response.

Advertisements
Mark J. Holterman, Medical

CellR4 – Journal for Cellular Therapies

 

CellR4pic
CellR4
Image: CellR4.org

A pediatrics and surgical professor at the University of Illinois College of Medicine, Mark Holterman, MD, holds board positions with multiple medical organizations. Dr. Mark Holterman also is a cofounder of the Alliance for the Advancement of Cellular Therapies (AACT) and serves on its executive board. The AACT collaborates with the CellR4 medical journal to publish research presented at AACT conferences.

The official journal of the Cure Alliance, CellR4 focuses on studies and medical knowledge regarding cellular repair, regeneration, reprogramming, and differentiation. The journal facilitates discussion on challenges and opportunities involved in developing new treatments. Published content includes information on fundamental new discoveries in basic science and the delivery of innovative therapies to transitional and clinical trials. Additionally, CellR4 shares information on global collaborative efforts and features commentaries and opinion papers on legal, ethical, and regulatory issues.

CellR4’s articles are available for full download at no charge on its website.

Mark J. Holterman, Medical

AACT Joins Patients for Stem Cells to Fight for Cellular Therapies

 

Alliance for the Advancement of Cellular Therapies pic
Alliance for the Advancement of Cellular Therapies
Image: aact.co

Dr. Mark J. Holterman serves as a professor at the University of Illinois College of Medicine. In addition to teaching classes in the fields of pediatrics and surgery, Dr. Mark J. Holterman maintains a professional interest in therapies derived from stem cells. He is accordingly a member of the Alliance for the Advancement of Cellular Therapies (AACT).

AACT is an up-and-coming alliance devoted to creating new cellular therapies. It focuses heavily on adult stem cells and their many applications in cellular therapy. To this end, AACT works with leaders in science, health care, and politics to promote understanding of and support for stem-cell-based therapies.

In 2015, AACT joined forces with Patients for Stem Cells, a grassroots patients’ rights group. Both organizations share the common goal of using evidence-based medicine to allow patients to access their own stem cells. The nonprofits are now working together to promote cell therapy and help patients overcome the many barriers to treatment.